SYALOX CIS

28 tablets + 28 capsules

SyaloxCis is a Food Supplement based on High Molecular Weight Hyaluronic Acid, Chondroitin sulphate, Hibiscus and Uncaria Plant Extracts and Live Lactic Ferments. Hibiscus contributes to the functionality of the urinary tract while Uncaria helps the body's natural defenses.

Syalox Cis is the effective, quick and safe answer in all cases of acute and recurrent cystitis.

Description

Syalox Cis tablets contain:
Hyaluronic Acid (HA), a natural organic compound, synthesised by fibroblasts and made up of repetitive sequences of D-Glucuronic Acid and N-Acetyl D-Glucosamine.
The main function of HA, in most biological processes, is to maintain the structural and functional characteristics of fluids and extracellular matrix such as tissue protection and repair.
Chondroitin sulfate, is a glycosaminoglycan and as such is part of the normal constitution of the extracellular matrix of connective tissues.
Hibiscus (Hibiscus sabdariffa L.), a plant belonging to the Malvaceae family, favours the functionality of the urinary tract.
Uncaria (Uncaria tomentosa Wild. ex Shult. DC.), A plant deriving from the Rubiaceae, useful for the body's natural defenses.
Syalox Cis Probiotics in capsules originally contains 12 billion live cells, divided into two particular strains: Lactobacillus acidophilus and Lactobacillus reuteri, useful for counteracting the proliferation of pathogenic bacteria responsible for cystitis, restoring the balance of the intestinal bacterial flora.

Pharmaceutical form

Capsules and Tablets - 28 capsules of 0.45 g each + 28 tablets of 1.2 g each. - Gluten Free.

Application

Take 1 tablet + 1 capsule of Syalox Cis per day, in the evening after the last urination, before going to bed.

Information / Warnings

Food Supplements are not intended as a substitute for a varied, balanced diet and a healthy lifestyle.
Do not exceed the recommended daily dose.
Keep out of the reach of children under 3 years of age.
Do not take in case of hypersensitivity or allergies to one or more components.

Nutritional table

Average contents for 1 tablet
Hyaluranic Acid Sodium Salt 100 mg
Chondroitin sulfate 200 mg
Hibiscus dry extract.
tit. 5% Polyphenols
200 mg
Uncaria d.e.
tit. 2,5% Oxindole Alkaloids
200 mg
Lactobacillus acidophilus - PBS 066 30 mg
1 Mld/CFU*
Lactobacillus Reuteri - PBS 072 30 mg
1 Mld/CFU*


*CFU Colony Forming Units

You may also be interested in:

River Pharma products represent progress for the Medical-Scientific Community, as well as the response to the most widespread ailments and diseases in the world.

SYALOX 300 PLUS

SYALOX 300 PLUS

Syalox 300 Plus is indicated in all clinical situations characterised by joint pain and reduced mobility.

Discover the product
NEVRALCAR DUO

NEVRALCAR DUO

The Synergy of the 2 Active Ingredients allow pain control in all those clinical situations characterized by Neuropathy of both joint and metabolic origin.

Discover the product

River Pharma: Healthcare is Our Passion

Dermocosmetics

Products that contain, Hyaluronic Acids with a careful selection of molecular weight, amongst other things and are characterised by their anti-ageing effectiveness.

Find out more

Nutraceuticals

State-of-the-art products based on high molecular weight Hyaluronic Acid obtained through bio-fermentation technology and are characterised by their effectiveness proven in five distinct therapeutic areas.

Find out more

Medical Devices

The latest generation of medical devices based on Hyaluronic Acid with a high molecular weight, 2 mil D, to be injected, effective for the treatment and prevention of osteoarticular pathologies linked to ageing and for the treatment of acute trauma. 

Find out more

Science Informs: The River Pharma Blog

Stay up to date, learn more about the research and insights of the most authoritative members of the International Medical-Scientific Community.

Menopause and osteoporosis: what causes bone loss?

Menopause and osteoporosis: what causes bone loss?

Unfortunately for all women who are in menopause osteoporosis is a sad reality that sooner or later will become increasingly present in their lives, this is even more true in all those who already have a genetic predisposition towards this degenerative bone disease.

Keep reading

Iscriviti alla nostra Newsletter

Il tuo appuntamento con la Scienza non si ferma mai. Registrati e rimani sempre aggiornato sulle notizie, gli approfondimenti, gli studi e le soluzioni terapeutiche più all’avanguardia.